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Abstract The varying clinical manifestations of Lyme bor-
reliosis, transmitted by Ixodes ricinus and caused by Borre-
lia burgdorferi, frequently pose diagnostic problems.
Diagnostic strategies vary between early and late disease
manifestations and usually include serological methods.
Erythema migrans is pathognomonic and does not require
any further laboratory investigations. In contrast, the diag-
nosis of neuroborreliosis requires the assessment of serum
and cerebrospinal fluid. Lyme arthritis is diagnosed in the
presence of newly recognized arthritis and high-titer serum
IgG antibodies against B. burgdorferi. The committee con-
cludes the following recommendations: Borrelial serology
should only be ordered in case of well-founded clinical
suspicion for Lyme borreliosis, i.e., manifestations com-
patible with the diagnosis. Tests for borrelial genomic
sequences in ticks or lymphocyte proliferation assays
should not be ordered. When results of such tests or of
serological investigations that were not indicated are
available, they should not influence therapeutic decisions.
Laboratories should be cautious when interpreting results
of serological tests and abstain from giving therapeutic
recommendations and from proposing retesting after
some time without intimate knowledge of patient's his-
tory and disease manifestations.
A previous version of these recommendations has been published in
German language in Kinderärztliche Praxis (2011; 82:122) and on the
website of the German Academy for Pediatrics and Adolescent Health
(www.dakj.de).
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Introduction
Lyme borreliosis is caused by infection with Borrelia burg-
dorferi sensu lato and transmitted by the bite of the tick
Ixodes ricinus [26]. In Europe, Lyme borreliosis may
present as a variety of manifestations that are classified into
early and late manifestations in children and adolescents
[12] (Table 1). The correct diagnosis is made or is at least
strongly suggested by history and physical examination.
Borrelia-specific laboratory results confirm the clinical sus-
picion [31]. Besides the direct methods for detecting the
infectious agents in body fluids or tissues, for example, by
polymerase chain reaction (PCR), serological methods are
usually used on blood and cerebrospinal fluid. Primarily,
enzyme immunoassays, distinguishing between immuno-
globulin M and G antibodies, are applied as screening tests.
Because of their low specificity, (line) immunoblot assays,
often with recombinant antigens, are used as confirmatory
assays in case of a reactive (positive or borderline) enzyme
immunoassay [7]. A few antigens are especially helpful
including VlsE and OspC for early disease and p83/100
for late borreliosis. By comparing antibody concentrations
in serum and cerebrospinal fluid, it is possible to detect
intrathecal antibody production [18].
These diagnostic strategies were established more than
10 years ago, and scientific progress, since then, is minimal.
Although there are good review articles, for example, in the
handbook of the German Society for Pediatric Infectious
Diseases [21], diagnosing Lyme borreliosis continues to be
difficult, and therefore, a rational strategy is presented here
for everyday use. The diagnostic strategies discussed here
apply to European, but not necessarily to North American
Lyme borreliosis.
Table 1 Manifestations of Lyme borreliosis in children and adolescents (modified from Huppertz [12])












































None Episodic arthritis, 
chronic arthritis
Early manifestations can be observed after some days up to a few weeks after infection and are self-limiting. Assessment of antibodies in serum
may still be unremarkable or show an early seroconversion including IgM antibodies and low-titer IgG antibodies against B. burgdorferi. Late
manifestations show up months to years after infection, may become chronic and, in rare cases, lead to lasting organ damage. Serological results
show high-titer IgG antibodies against B. burgdorferi; IgM antibodies may persist. EIA enzyme immunoassay, IB immunoblot
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Erythema migrans
Erythema migrans is by far the most frequent manifestation
of Lyme borreliosis in Europe, amounting to nearly 90 %
of all cases [13]. Clinical presentation of erythema migrans
is pathognomonic, and therefore, usually no laboratory
tests are necessary for diagnosis [26]. Because serology is
frequently negative at this stage, antibodies should not be
determined. In rare cases of atypical erythema migrans,
clinical diagnosis may be difficult. In these cases, the
present extent of the erythema may be marked with a pen
and should be reexamined 1–2 days later. If the erythema
has expanded, the diagnosis of erythema migrans is most
likely correct. PCR of skin biopsy is a good test to confirm
a diagnosis of erythema migrans, and results are truly
positive in about 70 % of cases when good biopsy and
laboratory techniques are used [3]. However, skin biopsy is
seldom justified. Response to antibiotic treatment is only
confirmed by disappearance of erythema migrans and not
by serological means.
Other manifestations
When other manifestations of Lyme borreliosis are sus-
pected, and erythema migrans is not present, serological
assays should be performed [31].
Suspicion of early neuroborreliosis
Lyme borreliosis should be considered in patients with
cranial nerve palsy, in particular, seventh nerve palsy, and
signs of meningitis with or without headache, lethargy, or
irritability for about 9 days on average before admission
[25, 27]. Stiffness of the neck is often very mild or absent
and must be searched for carefully. In contrast, patients
with aseptic/viral meningitis usually display obvious
nuchal rigidity and have a history of less than 6 days, often
1 or 2 days only [4, 27]. Especially in the absence of
cranial nerve palsy, the possible diagnosis of Lyme borre-
liosis is not being considered often enough. Patients with
headache as a sole manifestation usually do not have
neuroborreliosis. In comparison to patients with noninflam-
matory headaches of frequent and various causes, the head-
aches of patients with neuroborreliosis usually have a
clearly indicated beginning and a short duration of less
than a month [27]. To confirm neuroborreliosis, antibodies
against Borrelia burgdorferi are assessed in serum and
cerebrospinal fluid. In the case of early neuroborreliosis,
there is lymphocytic pleocytosis in the cerebrospinal fluid,
but often, intrathecal antibody production cannot yet be
found [24]. If cerebrospinal fluid yields pleocytosis with
≥90 % mononuclear cells, there are no other remaining
causes apart from tuberculous meningitis. In very early
stages of the disease, serological results in serum may still
be negative [4]. In typical cases, antibodies of the immu-
noglobulin IgM class against B. burgdorferi are found by
enzyme immunoassay and are confirmed by two or more
bands by IgM immunoblot. Later, IgG antibodies may be
detected by enzyme immunoassay, and the number of
bands in the IgG immunoblot increases gradually. There-
fore, in case of a negative serology and continuing suspi-
cion of neuroborreliosis, it may be useful to determine
antibodies in serum again 2 or 3 or 4 weeks later to find
seroconversion. PCR in cerebrospinal fluid often is positive
only in very early cases when there are not yet antibodies
against B. burgdorferi present. Although a positive PCR
supports the diagnosis of neuroborreliosis, a negative PCR
does not exclude it [18]. Therefore, PCR should not be
used routinely to make a diagnosis of neuroborreliosis, but
only in complex cases.
Suspicion of late neuroborreliosis
The neurological manifestations have usually been present
for some time, and a number of different diagnoses have
been considered, including multiple sclerosis, Guillain–
Barré syndrome, pseudotumor cerebri, and cerebral vascu-
litis. The clinical presentation may be varying, including
headache, lethargy, irritability, and focal neurological signs.
Late neuroborreliosis is very rare in children.
Lymphocytic pleocytosis is not necessarily found in cere-
brospinal fluid, since it may occur intermittently. However,
there is borrelia-specific intrathecal antibody production, usu-
ally of immunoglobulin G [18]. In addition, there are intra-
thecal oligoclonal bands and a high protein concentration in
cerebrospinal fluid. In serum, there is a positive enzyme
immunoassay for IgG antibodies against B. burgdorferi, con-
firmed by IgG immunoblot with a multitude of bands.
Suspicion of Lyme arthritis
In the case of newly appearing arthritis, a borrelial serology
should be obtained, especially in mono- or oligoarthritis,
including the knee joint [14]. In case of Lyme arthritis, the
enzyme immunoassay is highly positive for IgG antibodies
against B. burgdorferi; the results of which are confirmed by
immunoblot with a multitude of bands. PCR in synovial fluid
may be positive. The rate of correctly positive results by PCR
may be increased by using synovial tissue. However, the sus-
picion of Lyme arthritis is not sufficient justification for per-
forming a synovial biopsy, and laboratory confirmation of the
diagnosis primarily relies on serum antibody determination.
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Suspicion of further manifestations
There is a variety of further rare manifestations of Lyme
borreliosis. When there is a reasonable suspicion of Lyme
borreliosis, diagnosis is supported by serology. The expected
serological results vary with the stage of the disease, i.e., if the
patient has an early or late manifestation of Lyme borreliosis.
Eyes may be involved by keratitis, iridocyclitis, or uveitis
intermedia. Cardiac involvement may appear as AV block or
carditis. Acrodermatitis chronica atrophicans is a late skin
manifestation of borreliosis and very rare in children. In
borrelial lymphocytoma, usually found at earlobes, nipples,
or testicular sacks, serology is not infrequently false negative.
Therefore, diagnosis may be established exclusively by clin-
ical means, as is the case for erythema migrans. The issue of
summer flu, including fever, joint pain, and fatigue without
signs of mucous membrane involvement is still unclear,
although it may be a manifestation of early Lyme borreliosis.
The clinical presentation is too varied, and serological exami-
nations often are still negative, or false positive serological
results lead to misdiagnosis and unnecessary treatment [23].
The disease usually is self-limiting after a few days.
Mental state disturbances and vague somatic symptoms
(false manifestations of Lyme borreliosis)
Borreliosis is sometimes suspected in patients with func-
tional problems or mental state disturbances. However,
symptoms usually do not fit with known manifestations of
Lyme borreliosis [9].
In case of chronic headache or diminishing academic
achievements, often patients are not able to indicate when
complaints started, which is not typical of neuroborreliosis.
If suspicion of neuroborreliosis remains, lumbar puncture
should be performed, which excludes neuroborreliosis if find-
ings are normal, i.e., absence of pleocytosis and intrathecal
antibody production. If antibody determination is only being
done in serum, the result is without relevance for the cause of
headaches, and frequently, serological results cannot be inter-
preted in the absence of results from cerebrospinal fluid [2].
In case of muscular and skeletal complaints, sometimes
Lyme arthritis is suspected, although arthritis is missing, a
sign which is necessary for the diagnosis of Lyme arthritis.
If serology has been performed in spite of the absence of
arthritis, the lack of antibodies of immunoglobulin G against
B. burgdorferi excludes Lyme arthritis. If this determination
of specific IgG antibodies is positive, anti-B. burgdorferi
antibody production has been detected; however, the cause
of musculoskeletal pain remains unclear in the absence of
arthritis. This is due to the fact that the positive predictive
value is low if the prevalence of the tested trait is low [23].
Moreover, when assays for antibodies against B. burgdorferi
are ordered in patients with an absence of objective signs of
manifestations compatible with Lyme borreliosis, serology
often cannot be interpreted. Therefore, in case of nonspe-
cific complaints like headache, limb pain, or mental state
disturbance, borrelial serology should not be performed.
Recommendations by laboratories concerning
the interpretations of serological results
The interpretation of results of serology for B. burgdorferi
may be difficult and sometimes is indeterminate. Interpreta-
tion should always be done in conjunction with complete
clinical knowledge of the patient.
Some laboratories recommend that borrelial serology be
repeated after a few weeks or months. However, this only
rarely leads to new evidence. An exception from this rule is
early disseminated disease, including early neuroborreliosis.
Therefore, serology should be repeated after an interval of
time only in very few well-founded cases.
Sometimes the interpretation of serology results by labo-
ratories contains recommendations for treatment. However,
this would require complete knowledge of clinical presenta-
tion and previous therapeutic measures. As these are usually
not available in the laboratory, these recommendations often
are inaccurate or wrong.
In addition to these, other diagnostic strategies have been
recommended: The analysis of ticks which have been
removed from human skin for the presence of borrelia, and
the assessment of the ability of lymphocytes from peripheral
blood to proliferate after addition of borrelial antigens.
Analysis for borrelia of ticks which have been removed
from human skin
Some laboratories recommend and advertise assessing ticks
by PCR for borrelial genomic sequences when they have
been removed from the skin of a human host. Laboratories
report the presence of borrelia, sometimes also the genotype
and the number of copies. In case of a positive result, these
laboratories recommend either antibiotic prophylaxis or
serological assessment immediately and a few weeks later
to detect seroconversion.
There are no convincing data, justifying the use of these
tests in ticks removed from humans or patients. There are no
data presented for false positive results. It is not known why
the number of copies is relevant, since the minimal infec-
tious dose of B. burgdorferi is not known [6]. If the geno-
type is not indicated, nonpathogenic genotypes may be
included under the general term B. burgdorferi sensu lato,
thus exaggerating the potential risk of transmission. In a
study from Switzerland, a positive test result finding borrelia
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in removed ticks was not associated with the development
of Lyme borreliosis [19].
The assessment of ticks for borrelial genomic sequences
overestimates the importance of a single tick bite, since most
tick bites are not recognized by the host, and most patients
with Lyme borreliosis do not remember having been bitten by
a tick [11]. When people recognize a tick on their skin and
remove it early (i.e., within 24 h), most of the time, borrelia is
not transmitted [30]. The risk of transmission after a tick bite is
given as 4 % [8]. In a Swiss study, seroconversion occurred in
4.5 % of tick bites [18]. Most infections take an uneventful
course without clinical manifestations [19]. Asymptomatic
seroconversion and clinical infection are low in spite of a high
percentage of infection by B. burgdorferi in ticks removed
from these humans [11]. Up to 5 % of healthy blood donors
display IgG antibodies against B. burgdorferi [1]; healthy
forest workers, up to 52 % [20]. In German children, this rate
currently is 4.8 % [22]. The apparently low transmission rate
and the high proportion of asymptomatic borrelia infections
after tick bites do not justify the search for borrelial genomic
sequences in a removed tick. In addition, a positive result does
not allow a reasonable conclusion: prophylactic antibiotic
treatment after a tick bite is not recommended in Europe the
more so as this treatment may not prevent infection followed
by clinical manifestations [17]. Even if seroconversion is
detected after a tick bite, found in paired serum assessments
at an interval of 3–4 weeks, this finding is without consequen-
ces in the absence of clinical manifestation, since antibiotic
treatment would only be recommended if the patient gets sick
with borreliosis. In conclusion, the assessment of borrelial
sequences or antigens in ticks removed from patients is with-
out therapeutic consequence, and therefore, the test should not
be performed [10].
Assessment of the reaction of lymphocytes
towards borrelia antigens
Plasma cells producing antibodies are under the control of T
cells during their development. Early attempts to assess the
reactivity of T cells towards borrelial antigens used the
lymphocyte transformation assay. In spite of refined tests
and use of recombinant antigens, it was not possible to
obtain the same specificity as in serological methods includ-
ing enzyme immunoassay and immunoblot [5, 15, 16].
Consequently, the lymphocyte transformation assay has
not been recommended for clinical use.
Recently, there have been new attempts to introduce this test
into the diagnosis of Lyme borreliosis [28, 29]. This was based
on further technical improvements of the tests. In two publica-
tions, a good performance of these tests has been reported [28,
29]. Closer examination of these publications, however, shows
that the patients had not been characterized, and the suspicion
of the physician, sending the probe to the laboratory (“suspi-
cion of borreliosis”), was taken as a diagnosis. Serological
results were not communicated for all patients, and correct
control groups were missing. Consequently, these publications
are not able to contribute to the assessment of the validity of the
lymphocyte transformation assay. Therefore, results of these
tests cannot contribute to the management of patients.
Conclusions of the committee
The following consequences should be drawn:
1. The committee recommends that pediatricians order bor-
relial serology only when there is a well-founded clinical
suspicion of Lyme borreliosis following the diagnostic
strategy outlined above. Patients with chronic pain,
fatigue, or mental state disturbances should not be tested
for Lyme borreliosis.
2. The committee recommends that insurance companies do
not pay for laboratory assessments that are not indicated.
This includes serological tests without well-founded clin-
ical suspicion, tests for borrelial antigens or genomic
sequences in ticks, and lymphocyte transformation assays.
3. The committee strongly recommends that laboratories
that offer serological examination for Lyme borreliosis
should never add therapeutic recommendations when
interpreting the laboratory results. Without close knowl-
edge of clinical manifestations and previous therapeutic
measures, it is not possible to reason about therapeutic
consequences of serological results.
4. In addition, the committee asks laboratories not to recom-
mend further serological assessments after a few weeks or
months when interpreting serological results. In most
cases, repetition of serology does not add useful new
evidence. Only the attending physician with close knowl-
edge of history, clinical manifestations, and previous
treatments may decide on the usefulness of repeating the
serology after 2 or 3 or 4 weeks in a given patient.
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